Receptor Pharmacology of MDMA and Related Hallucinogensa
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The data presented herein appear to strongly implicate the brain 5HT2 receptor as the site-of-action of the hallucinogenic PIAs and LSD. If so, this discovery represents a major step in understanding the molecular pharmacology of hallucinogenic drugs. Using radioactive hallucinogenic drugs, detailed properties of brain 5HT2 receptors indicating the interaction of 5HT2 receptors with GTP-binding proteins have been revealed. Autoradiographic studies have revealed an extensive cortical distribution of brain 5HT2 receptors; these studies have also suggested that the PIAs may be 5HT1C agonists. Radiolabeling studies in conjunction with drug discrimination studies indicate that MDMA is apparently "amphetamine-like" and not "LSD-like" while MDA is apparently both "LSD-like" and "amphetamine-like." However, MDMA does appear to possess the potential to act as a 5HT2 agonist at high dosages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lysergic acid diethylamide: Sensitive neuronal units in the midbrain raphe
Aghajanian, G. K., Foote, W. E., & Sheard, M. H. (1968) · Science · doi:10.1126/science.161.3842.706 · Cited by 404
Cited by
Cathinone derivatives: A review of their chemistry, pharmacology and toxicology
Kelly, J. P. (2011) · Drug Testing and Analysis · doi:10.1002/dta.313 · Cited by 346
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Fantegrossi, W. E., Woods, J. H., & Winger, G. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200403000-00007 · Cited by 101
Modulation of Social Cognition via Hallucinogens and “Entactogens”
Preller, K. H., & Vollenweider, F. X. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00881 · Cited by 71
Anxiolytic drug discovery: What are the novel approaches and how can we improve them?
Stewart, A. M., & Kalueff, A. V. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.857309 · Cited by 22
“However, despite their ‘rich’ pharmacology, which includes the ability to act via multiple receptor mechanisms, hallucinogens remain poorly understood in both terms of their pharmacodynamics and the resultant behavioral responses [62,63].”
Background
Metadata
- Authors
- TEITLER, M., LEONHARDT, S., APPEL, N. M., DE SOUZA, E. B., & GLENNON, R. A.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 1990-10
- Volume
- 600
- Issue
- 1
- Pages
- 626-638
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2085920567
- Cited by
- 33
- References
- 1
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Receptor Pharmacology of MDMA and Related Hallucinogensa. https://app.cochat.ai/papers/10.1111/j.1749-6632.1990.tb16915.x
- The paper
- TEITLER, M., LEONHARDT, S., APPEL, N. M., DE SOUZA, E. B., & GLENNON, R. A. (1990). Receptor Pharmacology of MDMA and Related Hallucinogensa. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1990.tb16915.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.